title: Growth in children with established renal failure--a Registry analysis (chapter 14).
abstract: Short stature is a major problem in paediatric ERF patients with 29% of transplant patients and 41% of dialysis patients below the second percentile for height. Only 6.5% of transplant patients and 15.5% of dialysis patients are receiving rhGH. There is no significant difference in the height distribution of patients commencing RRT and those who have had a functioning allograft for at least 1 year. In patients with at least 2 years between presentation and RRT, there is a significant fall in height Z score. This overall statistic is strongly influenced by the very poor growth of patients with glomerular disease.
authors.affiliation: Central Manchester & Manchester Childrens University Hospitals NHS Trust, UK. malcolm.lewis@cmmc.nhs.uk
authors.forename: Malcolm
authors.initials: M
authors.lastname: Lewis
authors.forename: Joanne
authors.initials: J
authors.lastname: Shaw
authors.forename: Chris
authors.initials: C
authors.lastname: Reid
authors.forename: Jonathan
authors.initials: J
authors.lastname: Evans
authors.forename: Nicholas
authors.initials: N
authors.lastname: Webb
authors.forename: Kate
authors.initials: K
authors.lastname: Verrier-Jones
mesh_terms: D000293:Adolescent; D001827:Body Height; D002648:Child; D002657:Child Development; D002675:Child, Preschool; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D012042:Registries / Q000706:statistics & numerical data; D051437:Renal Insufficiency / Q000628:therapy*; D017582:Renal Replacement Therapy / Q000706:statistics & numerical data*; D006113:United Kingdom
chemical_list: D019382:Human Growth Hormone